Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 10

Results For "drugs"

997 News Found

NPPA monitors and caps prices of essential drugs: Mandaviya
Policy | August 03, 2021

NPPA monitors and caps prices of essential drugs: Mandaviya

NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level


Aarti Drugs posts Q1FY22 consolidated PAT at Rs. 48.81 Cr
News | July 28, 2021

Aarti Drugs posts Q1FY22 consolidated PAT at Rs. 48.81 Cr

The company posted net profit f Rs.85.45 crores for the period ended June 30, 2020.


Aarey Drugs and Pharmaceuticals Q4FY21 PAT at Rs. 1.40 Cr
News | June 30, 2021

Aarey Drugs and Pharmaceuticals Q4FY21 PAT at Rs. 1.40 Cr

The company has reported total income of Rs.355.43 crores during FY 2020-21


Mangalam Drugs commissions intermediate manufacturing facility
News | June 19, 2021

Mangalam Drugs commissions intermediate manufacturing facility

This will enable Mangalam to reduce its reliability on Chinese imports for this product and also help to maintain an uninterrupted supply chain to a great extent


Zydus Cadila receives tentative approval from USFDA for lung cancer drugs
Policy | June 03, 2021

Zydus Cadila receives tentative approval from USFDA for lung cancer drugs

Osimertinib works by slowing or stopping the growth of cancer cells and binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors


Zydus new initiative to safeguard patients against counterfeit drugs
News | May 29, 2021

Zydus new initiative to safeguard patients against counterfeit drugs

The patients can check to see if the product purchased by them is genuine or not by scratching the surface and verifying the code through the app or the website


Govt. monitoring supply of COVID-19 essential drugs
News | May 21, 2021

Govt. monitoring supply of COVID-19 essential drugs

Availability of drugs is being monitored by implementing a three-pronged strategy of supply chain management, demand side management, and affordability.


Aarti Drugs Q4FY21 consolidated net profit drops to Rs. 51.65 Cr
News | May 16, 2021

Aarti Drugs Q4FY21 consolidated net profit drops to Rs. 51.65 Cr

Aarti Drugs has reported total income of Rs.2159.30 crores during the 12 months period ended March 31, 2021


Alembic announces USFDA approval for two drugs
News | May 06, 2021

Alembic announces USFDA approval for two drugs

Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution USP, 2% and 0.5% has an estimated market size of US $80 million for twelve months ending December 2020 according to IQVIA


Government allocates over Rs. 10,000 Cr in PLI scheme for bulk drugs and medical devices: Gowda
News | February 26, 2021

Government allocates over Rs. 10,000 Cr in PLI scheme for bulk drugs and medical devices: Gowda

The Govt. launched the PLI scheme for bulk drugs with a financial outlay of Rs 6,940 crores across 53 APIs over 6 years.